GCM
VCEL icon

Geneva Capital Management’s Vericel Corp VCEL Stock Holding History

Geneva Capital Management’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.6M Sell
1,339,123
-307,695
-19% -$11.1M 1.37% 25
2026
Q1 		$53M Sell
1,646,818
-179,907
-10% -$6.39M 1.13% 32
2025
Q4 		$65.8M Sell
1,826,725
-119,580
-6% -$4.39M 1.24% 27
2025
Q3 		$61.3M Buy
1,946,305
+161,378
+9% +$5.79M 1.05% 36
2025
Q2 		$75.9M Buy
1,784,927
+419,183
+31% +$17.4M 1.27% 26
2025
Q1 		$60.9M Buy
1,365,744
+265,956
+24% +$14.3M 1.14% 28
2024
Q4 		$60.4M Sell
1,099,788
-4,598
-0.4% -$233K 1.05% 31
2024
Q3 		$46.7M Buy
1,104,386
+420,078
+61% +$20M 0.78% 43
2024
Q2 		$31.4M Buy
684,308
+5,143
+0.8% +$243K 0.57% 57
2024
Q1 		$35.3M Buy
679,165
+206,202
+44% +$9.04M 0.62% 54
2023
Q4 		$16.8M Buy
472,963
+37,784
+9% +$1.32M 0.32% 85
2023
Q3 		$14.6M Buy
+435,179
New +$15.1M 0.31% 87

Other funds holding VCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Geneva Capital Management's VCEL Position: Q2 2026 in Review

Geneva Capital Management reduced its Vericel Corp (VCEL) stake by 19% in Q2 2026, selling an estimated $11.1M and leaving 1,339,123 shares worth $59.6M. The position accounts for 1.37% of the portfolio, ranked #25.

Geneva Capital Management first reported a position in VCEL in Q3 2023 and has held it in 12 quarters since. The position peaked at $75.9M in Q2 2025. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Geneva Capital Management held 1,339,123 shares of Vericel Corp worth $59.6M as of Q2 2026.
  • Geneva Capital Management sold 307,695 Vericel Corp shares in Q2 2026, an estimated $11.1M.
  • Vericel Corp made up 1.37% of Geneva Capital Management's portfolio in Q2 2026, its #25 holding.
  • Geneva Capital Management first reported a position in Vericel Corp in Q3 2023 and has held it in 12 quarters since.
  • Geneva Capital Management's Vericel Corp position peaked at $75.9M in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.